Copyright
©The Author(s) 2023.
World J Diabetes. May 15, 2023; 14(5): 594-605
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.594
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.594
Table 1 Basic and clinical characteristics of all participants and those in the no severe intracranial and extracranial artery stenosis and artery stenosis groups
| Characteristics | All patients (n = 257) | NOCS group (n = 224) | AS group (n = 33) | P value |
| Age (yr) | 66.0 (11.0) | 66.0 (11.0) | 68.0 (12.0) | 0.236 |
| Male, n (%) | 121 (47.1) | 103 (46.0) | 18 (54.5) | 0.358 |
| Duration of T2DM (yr) | 12.0 (13.0) | 12.0 (14.0) | 13.0 (11.0) | 0.438 |
| Risk factors, n (%) | ||||
| 189 (73.5) | 165 (73.7) | 24 (72.7) | 0.910 | |
| 124 (48.2) | 112 (50.0) | 12 (36.4) | 0.143 | |
| 74 (28.8) | 63 (28.3) | 11 (33.3) | 0.548 | |
| 31 (12.1) | 22 (9.8) | 9 (27.3) | 0.004 | |
| 74 (28.8) | 67 (29.9) | 7 (21.2) | 0.303 | |
| 64 (24.9) | 59 (26.3) | 5 (15.2) | 0.165 | |
| BMI (kg/m2) | 25.76 (3.57) | 25.78 (3.59) | 25.76 (3.45) | 0.597 |
| Glucose (mmol/L) | 7.48 (3.58) | 7.49 (3.53) | 6.72 (4.25) | 0.563 |
| HbA1c (%) | 7.60 (2.50) | 7.60 (2.60) | 8.40 (2.90) | 0.037 |
| INS (µIU/mL) | 12.21 (12.71) | 12.00 (10.71) | 16.82 (18.93) | 0.159 |
| CP (ng/mL) | 2.33 (1.52) | 2.33 (1.53) | 2.40 (1.89) | 0.754 |
| TC (mmol/L) | 4.26 (1.50) | 4.27 (1.41) | 4.23 (2.25) | 0.721 |
| TG (mmol/L) | 1.48 (1.38) | 1.50 (1.39) | 1.41 (1.36) | 0.433 |
| LDL-C (mmol/L) | 2.38 (1.27) | 2.39 (1.20) | 2.27 (1.79) | 0.781 |
| HDL-C (mmol/L) | 1.12 (0.47) | 1.13 (0.47) | 1.04 (0.38) | 0.320 |
| Scr (µmol/L) | 62.0 (24.0) | 62.0 (22.8) | 60.0 (43.0) | 0.144 |
| Bun (mmol/L) | 5.98 (2.30) | 5.92 (2.12) | 6.82 (3.60) | 0.137 |
| UA (µmol/L) | 341.0 (126.5) | 342.0 (127.3) | 339.0 (1520) | 0.823 |
| OC (ng/mL) | 10.60 (5.87) | 10.27 (5.87) | 12.63 (7.07) | 0.001 |
| CTX (pg/mL) | 0.31 (0.21) | 0.29 (0.19) | 0.39 (0.30) | 0.007 |
| PINP (pg/mL) | 34.40 (20.96) | 33.39 (20.37) | 43.92 (25.50) | 0.010 |
Table 2 Basic and clinical characteristics of patients in the no severe intracranial and extracranial artery stenosis, intracranial artery stenosis, severe extracranial artery stenosis and combined severe intracranial and extracranial artery stenosis groups
| Characteristics | NOCS group (n = 224) | ICAS group (n = 19) | ECAS group (n = 8) | COAS group (n = 6) | P value |
| Age (yr) | 66.0 (11.0) | 65.0 (16.0) | 67.5 (13.0) | 71.0 (10.0) | 0.373 |
| Male, n (%) | 103 (46.0) | 10 (52.6) | 5 (62.5) | 3 (50) | 0.780 |
| Duration of T2DM (yr) | 12.0 (14.0) | 15.0 (11.0) | 18.0 (20.8) | 11.5 (7.0) | 0.635 |
| Risk factors, n (%) | |||||
| Hypertension | 165 (73.7) | 13 (68.4) | 5 (62.5) | 6 (100) | 0.527 |
| Hyperlipidemia | 112 (50.0) | 4 (21.1) | 7 (75.0) | 2 (33.3) | 0.029 |
| CAD | 63 (28.3) | 7 (36.8) | 2 (25.0) | 2 (33.3) | 0.826 |
| Previous stroke | 22 (9.8) | 4 (21.1) | 2 (25.0) | 3 (50.0) | 0.009 |
| Current smoker | 67 (29.9) | 4 (21.1) | 1 (12.5) | 2 (33.3) | 0.682 |
| Current drinker | 59 (26.3) | 4 (21.1) | 1 (12.5) | 0 (0) | 0.554 |
| BMI (kg/m2) | 25.78 (3.59) | 26.06 (3.90) | 25.32 (2.33) | 23.96 (12.48) | 0.821 |
| FPG (mmol/L) | 7.49 (3.53) | 7.83 (4.13) | 7.13 (6.89) | 5.76 (2.48) | 0.446 |
| HbA1c (%) | 7.60 (2.60) | 7.90 (3.10) | 9.15 (1.70) | 7.90 (1.80) | 0.067 |
| INS (µIU/mL) | 12.00 (10.71) | 16.99 (19.11) | 12.78 (19.72) | 15.90 (25.32) | 0.334 |
| CP (ng/mL) | 2.33 (1.53) | 2.52 (1.45) | 1.56 (2.95) | 2.03 (2.31) | 0.599 |
| TC (mmol/L) | 4.27 (1.41) | 3.85 (1.98) | 4.92 (2.35) | 4.35 (2.25) | 0.535 |
| TG (mmol/L) | 1.50 (1.39) | 1.59 (1.31) | 1.29 (1.31) | 1.16 (1.85) | 0.585 |
| LDL-C (mmol/L) | 2.39 (1.20) | 2.27 (1.76) | 2.62 (1.88) | 2.01 (2.27) | 0.943 |
| HDL-C (mmol/L) | 1.13 (0.47) | 0.98 (0.29) | 1.25 (1.21) | 1.04 (0.43) | 0.170 |
| Scr (µmol/L) | 62.0 (22.8) | 59.0 (48.0) | 78.5 (44.8) | 60.0 (40.3) | 0.499 |
| Bun (mmol/L) | 5.92 (2.12) | 6.36 (2.74) | 7.92 (6.76) | 6.57 (5.00) | 0.419 |
| UA (µmol/L) | 342.0 (127.3) | 358.0 (174.0) | 322.5 (153.3) | 303.0 (136.3) | 0.746 |
| OC (ng/mL) | 10.27 (5.87) | 12.76 (8.14) | 11.89 (4.02) | 15.15 (11.43) | 0.012 |
| CTX (pg/mL) | 0.29 (0.19) | 0.41 (0.29) | 0.35 (0.23) | 0.65 (0.51) | 0.027 |
| PINP (pg/mL) | 33.39 (20.37) | 41.25 (24.71) | 47.22 (39.85) | 51.28 (37.96) | 0.059 |
Table 3 Association of bone turnover biomarker levels with artery stenosis
| Variable | Model | OR (95%CI) | P value |
| OC | Model 1 | 1.123 (1.049-1.203) | 0.001 |
| Model 2 | 1.117 (1.041-1.199) | 0.002 | |
| Model 3 | 1.117 (1.039-1.201) | 0.003 | |
| Model 4 | 1.109 (1.029-1.196) | 0.007 | |
| CTX | Model 1 | 9.750 (1.759-54.059) | 0.009 |
| Model 2 | 8.674 (1.529-49.211) | 0.015 | |
| Model 3 | 10.833 (1.725-68.037) | 0.011 | |
| Model 4 | 8.526 (1.189-61.119) | 0.033 | |
| PINP | Model 1 | 1.024 (1.006-1.042) | 0.010 |
| Model 2 | 1.022 (1.003-1.041) | 0.025 | |
| Model 3 | 1.022 (1.003-1.042) | 0.021 | |
| Model 4 | 1.020 (1.001-1.040) | 0.044 |
Table 4 Spearman correlation coefficients for the associations between bone turnover biomarker levels and indicators of glucose and lipid metabolism
| Variable | OC | CTX | PINP | |||
| r | P value | r | P value | r | P value | |
| FPG | -0.102 | 0.103 | -0.134 | 0.031 | -0.141 | 0.024 |
| HbA1c | -0.012 | 0.846 | -0.022 | 0.724 | -0.012 | 0.845 |
| INS | -0.050 | 0.425 | -0.086 | 0.172 | -0.031 | 0.628 |
| CP | 0.021 | 0.741 | 0.045 | 0.473 | 0.067 | 0.286 |
| TC | 0.185 | 0.003 | 0.147 | 0.018 | 0.112 | 0.074 |
| TG | 0.020 | 0.753 | -0.058 | 0.351 | -0.041 | 0.514 |
| LDL-C | 0.213 | 0.001 | 0.187 | 0.003 | 0.129 | 0.039 |
| HDL-C | 0.020 | 0.745 | 0.062 | 0.319 | 0.015 | 0.811 |
- Citation: Si SC, Yang W, Luo HY, Ma YX, Zhao H, Liu J. Association of bone turnover biomarkers with severe intracranial and extracranial artery stenosis in type 2 diabetes mellitus patients. World J Diabetes 2023; 14(5): 594-605
- URL: https://www.wjgnet.com/1948-9358/full/v14/i5/594.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i5.594
